Member Info for ratcliffewriter

Not the first time Ivy's posted 'information' from being 'close to a director'.

Strange that Drac can find a route tondepression and pessimism at every turn here, yet was a champion hollerer for the bargain wreck that is Valirx while slating sclp at every turn. Something of a credibility gap methinks.

Of course substantial income would delay or negate a placing, but if they had genuine money coming in I'm sure they'd have said so.

I see the coffers as getting dangerously empty even now, but where do you see them out of interest?

And how come nobody mentions the TheoremRx money being imminent? Remember the '60 million ready and waiting in an offshore account' excitement? It was all utter fiction, so I'd treat any 'money round the corner' claims or hints with great caution. 'The cheque is in the post' is not a good basis for cash flow.

Alwayswatching - the 1p figure is based on a likely placing price given the sp today. The amount paid by today's RNS appears to be nothing until commercialisation, so when's that? 3 years, five years, ten years? 2.5 million a year needed just to pay running costs, so please tell me why a placing ISN'T a strong likelihood on past performance and remaining pennies in the coffers.

Next RNS (?) - In view of the last rns we now need funds to advance towards this next stage and are delighted to announce a placing at 1p to help this (and also to provide working capital to pay salaries, bonuses, travel expenses etc...)

Or is this not likely?

I suspect some of them are moonlighting as speech writers for Donald Trump.

The fee is likely not agreed at this point anyway - 'Inaphaea will be entitled to an upfront fee and a percentage of service royalties on commercialisation..' - looks like it's got to get to commercialisation (if it ever does) before money changes hands. Meanwhile the use of zebrafish could lead to a new wholly-owned company with a range of koi carp, pond liners, oxygenating plants and fountains.

Make that big pharma, rather than bug pharma.

Any thoughts on an alternative - reject any buyout, and Redmile use the data, the bug pharma interest and other highlights to gather a load of like-minded major investors and help Scancell go it alone, à la Biontech. Or something on those lines. Just pondering alternatives.

Next thing we'll have Aimbig calling him an alkaliar.

Are you trying to soft soap them to prevent them getting in a lather?

Hi AB124 - I forgot you had been following for so long, but you were just good old Aimbig in those days of course. It was of curse not the formulation of Moditope that overtook the plan for the sale of the company, but the decision to retain the assets and then do the placing to advance it.

Interested that you profess your greater knowledge and then say 'Looks like the whiners and bashers knew a great deal more about the Company's history than you!'

At least you have been upfront about your stance. Whiners and bashers - plural? So who are your compadres in these activities? Knowlesi possibly? He was very keen to scream 'lies, all lies' at the first sign of technical inaccuracy. Did you go to the same school perchance? I shall have to ask him a bit more about you when we next meet for a round of golf. He has actually mellowed since he stopped posting here.

But I digress - you have been so conspicuously absent during this recent sustained buying and rise, not even popping up to confront your arch enemy GF123. I was beginning to wonder if some tragic mishap had overtaken you, so you can imagine the scale of my joy to discover this has not been the case.

And the sell had no apparent effect on the sp. Most intriguing.

The RG Frankfurt 'sale of the company' was I believe a genuine path they intended to follow, and the louder whiners and bashers always conveniently ignore the fact that it preceded the creation of Moditope by a few months which completely changed the direction of the company - a direction which now looks to be on the cusp of delivering serious returns, all being well. So please, look at the Frankfurt comments in context and look at what has been built since.

True - if (whenever it comes) the news is poor, there's going to be someone who's lashed out one and a half million quid or so who'll be a lot more disappointed than me!

After such a sustained and persistent rise, and so much upcoming news and obvious systematic buying-in, I wonder if we will get a plug from Zac Mir with lots of pretentious graphs, lines and predictions? Probably not, because none of his pumpy spike-pushing joy/doom followers are going to ask him to give it a mention to help engineer a wave in the graph.

Indeed, could very very good for some, and as for the 'astute'? Matthew 13:42 beckons.

'So much potential locked into vals assets.....both treatments and executive business management.'

The management certainly have to be congratulated on getting so many placings away over the years. If anyone is doing their own research and not listening to either side of the arguments here, perhaps start by looking at the latest on the much-praised blockbuster that is VAL201 - it's so promising that a company who have a great track record at raising investment have taken almost three years to raise.......nothing.

I have watched this share for a good many years, waiting for a point where it might be investable, so If you are tempted to invest then most definitely DYOR - I have sat on the side lines as consolidation follows raises follows consolidation and so on. If I had put 10 grand in before the last consolidation it would be worth 80 quid. If that were two consolidations ago it would be 64p. Three consolidations ago - less than a halfpenny. But all the time there were regulars saying 'now is the time' and 'it can't go any lower.'

So yes, DYOR - read the RNSs and be objective. Then when a long-term stalwart pops up with 'its a perfect time to top up' ask yourself is it being said as a hot tip on a gem that you have somehow overlooked, or is it someone too blinkered or locked in to get out, who needs a spike to exit and leave you holding the baby. And ask what happened to johngilchrist, and where has PM2022 gone?

I realise it might put me in the 'happy clapper' sin bin for going against the attempts to raise the spectre of funding (in the absence of all the other usual scare tactics) but has it occurred to anyone that further funding may be part of a deal which will obviate the need for any form of placing at all, and an interested party who wants 'in' has only the open market available as an entry to taking a stake? Sorry if this exploration of an alternative doesn't qualify as 'balanced' but surely worthy of passing consideration. I suppose this possibility opens the door to doom-laden wails of 'insider leaking of information', but information flows in many ways, a lot of it with intact integrity. Or of course, as someone pointed out before there is the possibility of general good things spreading from the trials and certain parties just seeing a potentially great investment, although on the other hand this buying looks too organised and too persistent for just rumour-mill stuff.

It's another 'expert' trader - definition of an expert being 'an ex is a has-been and a spurt is a drip under pressure.'

Meanwhile, back in real life, let's see what this week brings.